328 related articles for article (PubMed ID: 17395699)
1. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
Kuzman JA; O'Connell TD; Gerdes AM
Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
[TBL] [Abstract][Full Text] [Related]
3. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
5. Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation.
Mourouzis I; Giagourta I; Galanopoulos G; Mantzouratou P; Kostakou E; Kokkinos AD; Tentolouris N; Pantos C
Metabolism; 2013 Oct; 62(10):1387-93. PubMed ID: 23773982
[TBL] [Abstract][Full Text] [Related]
6. Shp2 negatively regulates growth in cardiomyocytes by controlling focal adhesion kinase/Src and mTOR pathways.
Marin TM; Clemente CF; Santos AM; Picardi PK; Pascoal VD; Lopes-Cendes I; Saad MJ; Franchini KG
Circ Res; 2008 Oct; 103(8):813-24. PubMed ID: 18757826
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt/GSK-3beta/mTOR signaling pathway.
Diniz GP; Carneiro-Ramos MS; Barreto-Chaves ML
Basic Res Cardiol; 2009 Nov; 104(6):653-67. PubMed ID: 19588183
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
[TBL] [Abstract][Full Text] [Related]
9. 17ß-Estradiol regulates mTORC2 sensitivity to rapamycin in adaptive cardiac remodeling.
Kusch A; Schmidt M; Gürgen D; Postpieszala D; Catar R; Hegner B; Davidson MM; Mahmoodzadeh S; Dragun D
PLoS One; 2015; 10(4):e0123385. PubMed ID: 25880554
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways.
Clemente CF; Xavier-Neto J; Dalla Costa AP; Consonni SR; Antunes JE; Rocco SA; Pereira MB; Judice CC; Strauss B; Joazeiro PP; Matos-Souza JR; Franchini KG
J Mol Cell Cardiol; 2012 Feb; 52(2):493-501. PubMed ID: 22056317
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
12. PKD deletion promotes autophagy and inhibits hypertrophy in cardiomyocyte.
Zhao D; Gao Y; Wang W; Pei H; Xu C; Zhao Z
Exp Cell Res; 2020 Jan; 386(2):111742. PubMed ID: 31759056
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone stimulates protein synthesis in the cardiomyocyte by activating the Akt-mTOR and p70S6K pathways.
Kenessey A; Ojamaa K
J Biol Chem; 2006 Jul; 281(30):20666-20672. PubMed ID: 16717100
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional regulation of nuclear factor-κB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes.
Dhingra R; Gang H; Wang Y; Biala AK; Aviv Y; Margulets V; Tee A; Kirshenbaum LA
Circ Heart Fail; 2013 Mar; 6(2):335-43. PubMed ID: 23395931
[TBL] [Abstract][Full Text] [Related]
15. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
[TBL] [Abstract][Full Text] [Related]
17. Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling.
Ai W; Zhang Y; Tang QZ; Yan L; Bian ZY; Liu C; Huang H; Bai X; Yin L; Li H
J Cell Biochem; 2010 Aug; 110(5):1111-22. PubMed ID: 20564207
[TBL] [Abstract][Full Text] [Related]
18. L-Thyroxine activates Akt signaling in the heart.
Kuzman JA; Vogelsang KA; Thomas TA; Gerdes AM
J Mol Cell Cardiol; 2005 Aug; 39(2):251-8. PubMed ID: 15890358
[TBL] [Abstract][Full Text] [Related]
19. PKD knockdown inhibits pressure overload-induced cardiac hypertrophy by promoting autophagy via AKT/mTOR pathway.
Zhao D; Wang W; Wang H; Peng H; Liu X; Guo W; Su G; Zhao Z
Int J Biol Sci; 2017; 13(3):276-285. PubMed ID: 28367092
[TBL] [Abstract][Full Text] [Related]
20. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
